Journals / İstanbul Tıp Dergisi / 2011 / Cilt: 12 - Sayı: 2

A comparison of insulin resistance between hemodialysis and peritoneal dialysis patients

Hemodiyaliz ve sürekli ayaktan periton diyalizine giren hastalarda insülin direncinin karşılaştırılması

Pages
65–68
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patients were divided into two groups as the hemodialysis group (n: 51) and peritoneal dialysis group (n: 46), and their insulin resistance was compared with the Homeostasis Model Assessment (HOMA).Results: The mean HOMA in the peritoneal dialysis group (2.59±1.69) was statistically significantly higher than in the hemodialysis group (1.91±1.47) (p=0.036).Conclusion: Even though peritoneal dialysis removes medium-molecular-weight toxins better in dialysis patients compared to hemodialysis treatment, it affects insulin sensitivity unfavorably due to the hyperglycemia and hyperlipidemia burden caused by the glucose present in the dialysis solution.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Chronic renal failure is a permanent decrease in the glomerular filtration rate with increasing deterioration of renal function.
📊
Key Findings & Data:Decreased insulin sensitivity, insufficient release of insulin and increased hepatic gluconeogenesis contribute to insulin resistance in chronic renal failure.Methods: Ninety-seven patients (age range: 20-70, hemodialysis applied in 51 and peritoneal dialysis in 46), who were under follow-up and treatment at the Ministry of Health Istanbul Training and Research Hospital, Internal Medicine and Nephrology outpatient clinics, were included in our study.
💡
Conclusion & Impact:The patients were divided into two groups as the hemodialysis group (n: 51) and peritoneal dialysis group (n: 46), and their insulin resistance was compared with the Homeostasis Model Assessment (HOMA).Results: The mean HOMA in the peritoneal dialysis group (2.59±1.69) was statistically significantly higher than in the hemodialysis group (1.91±1.47) (p=0.036).Conclusion: Even though peritoneal dialysis removes medium-molecular-weight toxins better in dialysis patients compared to hemodialysis treatment, it affects insulin sensitivity unfavorably due to the hyperglycemia and hyperlipidemia burden caused by the glucose present in the dialysis solution.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Chronic renal failure is a permanent decrease in the glomerular filtration rate with increasing deterioration of renal function. Decreased insulin sensitivity, insufficient release of insulin and increased hepatic gluconeogenesis contribute to insulin resistance in chronic renal failure.Methods: Ninety-seven patients (age range: 20-70, hemodialysis applied in 51 and peritoneal dialysis in 46), who were under follow-up and treatment at the Ministry of Health Istanbul Training and Research Hospital, Internal Medicine and Nephrology outpatient clinics, were included in our study. The patients were divided into two groups as the hemodialysis group (n: 51) and peritoneal dialysis group (n: 46), and their insulin resistance was compared with the Homeostasis Model Assessment (HOMA).Results: The mean HOMA in the peritoneal dialysis group (2.59±1.69) was statistically significantly higher than in the hemodialysis group (1.91±1.47) (p=0.036).Conclusion: Even though peritoneal dialysis removes medium-molecular-weight toxins better in dialysis patients compared to hemodialysis treatment, it affects insulin sensitivity unfavorably due to the hyperglycemia and hyperlipidemia burden caused by the glucose present in the dialysis solution.

Özet

Amaç: Kronik böbrek yetmezliği, böbrek fonksiyonlarının giderek bozulması ile ortaya çıkan kalıcı glomerül filtrasyon hızının azalması ile kendini gösteren bir tablodur. Kronik renal yetmezliğinde azalmış insülin sensitivitesi, yetersiz insülin sekresyonu ve artmış hepatik glukoneogenezi insülin direncine katkı sağlar.Gereç ve Yöntem: Çalışmamıza, S.B. İstanbul Eğitim ve Araştırma Hastanesi İç Hastalıkları Kliniği ve Nefroloji Polikliniğinde takip ve tedavisi devam eden, 20-70 yaş arasında, 51’i hemodiyaliz, 46’sı periton diyalizi uygulanan 97 hasta alındı. Hastalar hemodiyaliz grubu ve periton diyalizi grubu olarak iki gruba ayrılarak insülin dirençleri Homeostatic Model Assessment (HOMA) ile karşılaştırıldı.Bulgular: Peritoneal diyaliz grubunun HOMA ortalamaları (2,59±1,69), hemodiyaliz grubundan (1,91±1,47) istatistiksel olarak anlamlı derecede yüksek bulundu (p=0,036).Sonuç: Peritoneal diyaliz hastalarında orta molekül ağırlıklı toksinlerin daha iyi uzaklaştırılmasına rağmen diyaliz solüsyonlarının içerdiği glukoz mevcudiyeti ve bunun getirdiği yük ile hiperglisemi ve hiperlipidemi hemodiyaliz tedavisine oranla insülin sensitivitesini olumsuz yönde etkilemektedir.

🔖

Cite This Article

ÖZGÜL, R. B., BESLER, M., MÜDERRİSOĞLU, C., GÜRCAN, Z. (2022). A comparison of insulin resistance between hemodialysis and peritoneal dialysis patients. İstanbul Tıp Dergisi, Cilt: 12 - Sayı: 2, 65–68. https://ajindex.com/articles/552573

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. İliçin G, Biberoğlu K, Süleymanlar G ve ark. Temel iç hastalıkları kitabı. Cilt 1. Ankara: Güneş Kitabevi; 1996. s. 769-802
  2. Akpolat T, Utaş C, Süleymanlar G. Nefroloji el kitabı. 3. baskı. İstanbul: Güzel Sanatlar; 2000. s. 249-306
  3. Mak RH, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992;61:377-82
  4. Mak RH. Insulin resistance in uremia: effect of dialysis modality. Pediatr Res 1996;40:304-8
  5. DeFronzo RA, Tobin JD, Rowe JW, et al. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978;62:425-35
  6. Perseghin G, Scifo P, De Cobelli F, et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 1999;48:1600-6
  7. Kahn CR, Rosenthal AS. Immunologic reactions to insulin: insulin allergy, insulin resistance, and the autoimmune insulin syndrome. Diabetes Care 1979;2:283-95
  8. Flier JS, Kahn CR, Roth J, et al. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science 1975;190:63-5
  9. Heaton A, Taylor R, Johnston DG, et al. Hepatic and peripheral insulin action in chronic renal failure before and during continuous ambulatory peritoneal dialysis. Clin Sci (Lond) 1989;77:383-8
  10. Hernández C, Genescà J, Ignasi Esteban J, et al. Relationship between iron stores and diabetes mellitus inpatients infected by hepatitis C virus: a case-control study. Med Clin (Barc) 2000;115:21-2
  11. Stefanović V, Nesić V, Stojimirović B. Treatment of insulin resistance in uremia. Int J Artif Organs 2003;26:100-4
  12. Mak RH. Insulin resistance in uremia: effect of dialysis modality. Pediatr Res 1996;40:304-8
  13. Balık İ, Yılmaz N, Türkçapar N ve ark. Kronik C hepatiti ve diabetes mellitus. Flora 1996;3:167-71
  14. DeFronzo RA, Smith JD. Is glucose intolerance harmful for the uremic patient? Kidney Int Suppl 1985;17:S88-97
  15. Dzurik R, Hupkova V, Cernacek P. The isolation of an metabolism in mammalian mucle by multivalantinhibitor of glucose utilazation from the serum of uremic subjects. Clin Chim Acta 1983;46:77
  16. Boen ST, Haagsma-Schouten WA, Birnie RJ. Single needle continuous flow haemodialysis without a control module. Proc Eur Dial Transplant Assoc 1977;14:596-7.